jhampton+FollowCan These Underdog Stocks Bounce Back?Ever wonder why some stocks get so much hate? Take Rivian, Tempus AI, and MP Materials—lots of folks are betting they’ll flop. But here’s the twist: Rivian’s new R2 car could finally make EVs more affordable, Tempus AI is quietly powering big pharma, and MP Materials has the only rare earth mine in the US (with the government as a top fan). Sometimes, the most doubted companies are the ones to watch for a surprise comeback! #Business #Market #stocks00Share
Jacqueline Howard DDS+FollowBiotech Stock Pops 60% on Cancer Drug BuzzHCW Biologics just had its wildest trading day in months—shares soared over 60% after news dropped about their next-gen cancer drug. They’re claiming it could outdo Merck’s Keytruda by not just unleashing the immune system, but also helping immune cells break into tough tumors. Early lab results look promising, and the hype is real: retail traders are piling in, and some are already cashing out big. Could this be the next blockbuster? #Health #BodyHealth #stocks276Share
Robert Evans+FollowWhy Everyone’s Buzzing About IINN StockHere’s a coffee break scoop: Inspira just scored a US patent for its ART500, a new breathing device that could shake up hospital care. Think of it as a high-tech backup for folks who need extra oxygen but aren’t in the ICU. Investors are piling in, hoping this tech will be a game-changer—though not everyone’s thrilled with the stock’s moves so far. If you’re into health tech or looking for the next big thing, keep an eye on this one! #Business #EntrepreneurshipStartup #stocks00Share
Robert Mayo+FollowWhy Everyone’s Watching CoreWeave Right NowCoreWeave’s stock took a nosedive after some big investors cashed out, but now there’s buzz it could bounce back. Jane Street, a major Wall Street player, just bought a big chunk of shares, which has retail traders feeling hopeful again. The drama? Some insiders are selling, but the company’s business is still solid. If you like buying the dip, this might be your kind of rollercoaster! #Business #Market #stocks61Share
russellolson+FollowWould You Buy a $2 Meme Stock Lottery Ticket?Ever thought about buying a stock for less than your daily coffee? Wheeler Real Estate (WHLR) is trading at just $2, and some Redditors are treating it like a scratch-off ticket. The company owns a bunch of shopping centers, but years of drama and debt have turned it into a penny stock. If you like high-risk, high-reward plays, this could be your wild card—but don’t bet the rent money! #RealEstate #stocks #investing10Share
Robert Mayo+FollowWhy Carlsmed Stock Is Still on My WatchlistCarlsmed’s stock has dipped 6% since its IPO, but Goldman Sachs thinks there’s a 35% upside. The buzz? Carlsmed’s tech could make spine surgeries smarter and more personal, and hospitals are about to get paid more for using their implants. Still, most regular investors aren’t buying the hype yet. If you’re into picking stocks with big potential, this could be one to keep an eye on for your next coffee break chat. #Business #Market #stocks00Share
Mark Sims+FollowRetail Traders Buzzing Over Sarepta’s Big PaydayCoffee break scoop: Sarepta just scored a $100M milestone payment thanks to progress in a rare genetic disorder trial, and retail investors are loving it. The twist? Sarepta sold a chunk of Arrowhead shares to help fund the payout, making both stocks pop. If you’re watching biotech, this is a classic case of how a single clinical trial update can send stocks on a wild ride. Just goes to show, sometimes the biggest moves come from behind-the-scenes deals! #Business #Market #stocks01Share
Allen Rios+FollowHow Insmed’s New Lung Drug Sent Stocks SoaringHeads up, money-watchers: Insmed just got the green light from the FDA for Brinsupri, the first-ever daily pill for a tough lung disease called NCFB. The stock popped to a 25-year high, and retail traders are buzzing. Why? This drug finally gives half a million Americans a new option, and with minimal side effects, it could be a game-changer. If you’re into biotech or just like a good underdog story, keep an eye on this one—it could be the next big thing in your portfolio. #Business #Market #stocks00Share
Allen Rios+FollowWould You Bet on CoreWeave’s Wild Ride?CoreWeave’s stock is the rollercoaster of the year—up 160% since its IPO, but already down 44% from its peak. Wall Street can’t decide if it’s a buy or a warning sign, but big tech’s AI spending spree is fueling the hype. The company just bought Core Scientific, giving it more control over its own tech playground. If you’re into high-risk, high-reward plays, this is one to watch, but don’t forget your seatbelt! #Business #Market #stocks20Share
jhampton+FollowStock Rockets 91%—Would You Jump In?CommScope just sold a big chunk of its business for $10.5 billion, and the stock shot up 91% in a day! The buzz is all about whether it’s still a bargain. The company plans to use the cash to pay off debt and might even send some money back to shareholders soon. If you’re into hunting for hot stocks, this one’s got everyone talking. #Business #Market #stocks01Share
